Aesthetic improvements are reported in 60–75% of participants in published series, but definitions of 'improvement' vary widely. Some studies use blinded photo assessment; others rely on patient self-reporting. Responders typically show modest gains—measurable skin firmness improvements and reduction in fine lines rather than dramatic reversal. Non-responders experience minimal visible change. Success depends heavily on baseline skin condition, age, and sun exposure history; outcomes are less predictable than surgical facelifts.
Nine registered clinical trials are currently tracking outcomes in aesthetic applications. Most focus on exosome infusions or fibroblast-derived serums applied topically or via micro-needling. Published studies report improvements in skin hydration, elasticity measurements, and subjective appearance scores over 8–12 weeks, though effect sizes vary. Placental extract trials have documented reductions in visible wrinkle depth in some cohorts. Evidence remains preliminary; long-term durability beyond 6 months is incompletely characterised. No major regulatory agency has approved stem cell-derived cosmetic products as therapeutic devices, though several are marketed as cosmeceuticals in jurisdictions with lighter oversight.
Am I a candidate? → · Aesthetic & Anti-Ageing: full overview → · Aesthetic & Anti-Ageing cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with the Stem Plus medical team (physicians & scientists · GMP-certified Sofia laboratory · 25+ yrs international experience) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估